Global markets,one institutional account.
Drovix gives banks, asset managers and corporate treasury desks multi-asset execution with auditable best execution, cross-margined capital efficiency and institutional reporting — under a single counterparty relationship and a single ISA.
Built for institutions that answer to committees, auditors and boards.
Banks, asset managers and corporate treasuries come to Drovix for institutional execution with a governance-grade paper trail: benchmarked fills, segregated collateral, named coverage and reporting their risk and audit functions can rely on. All counterparties are subject to onboarding, KYB, suitability, credit and jurisdictional review.
One account for global markets
FX, indices, commodities, metals and digital assets under a single ISA and a single collateral pool — one counterparty relationship instead of a patchwork of venues.
Auditable best execution
Every fill benchmarked and reported. Fill-level TCA gives boards, investment committees and auditors the evidence trail institutional governance requires.
Treasury & hedging programmes
Structured execution for corporate treasury desks managing FX exposure, commodity input costs or balance-sheet hedging — sized and scheduled around your programme.
Institutional risk reporting
Live exposure, margin projection, P&L tracking and customisable pre-trade parameters surfaced through institutional-grade dashboards your risk function can audit.
Dedicated relationship manager
A named institutional coverage point for onboarding, documentation, settlement corridors and operational support — not a ticket queue.
Segregated collateral handling
Margin and collateral held as cash collateral with custodian banks, segregated from Drovix's own funds and reconciled daily under the relevant client agreement.
Governance built in
Execution your committees can audit.
Margin and collateral held as cash collateral with custodian banks, segregated from Drovix's own funds and reconciled daily.
Structured execution for treasury desks managing FX exposure, commodity input costs or balance-sheet hedging.
Operational parameters describe the Drovix service framework. They are not guarantees of pricing, fill rates or trading outcomes. Collateral arrangements are set per the relevant client agreement.
How it works
One counterparty, governance-grade execution.
Drovix acts as a single principal counterparty for your institution's execution. Orders connect through FIX 4.4 or the portal, price against aggregated tier-1 and non-bank liquidity, and are internalised or routed to third-party liquidity providers to maintain best execution under prevailing market conditions.
- Single ISA covering FX, indices, commodities, metals and digital assets.
- Execution tailored to treasury, hedging or investment mandates.
- Collateral segregated with custodian banks and reconciled daily.
- Fill-level TCA and best-execution reporting for committees and auditors.
- Named relationship manager for documentation, settlement and operations.
Onboarding lifecycle
- 1Counterparty review
KYB, suitability, credit and jurisdictional review for the institutional entity.
- 2Mandate scoping
Treasury, hedging or investment mandate documented with instrument scope and limits.
- 3Documentation
ISA, settlement corridors and collateral arrangements agreed with your operations team.
- 4Connectivity
FIX 4.4 session or portal access configured; reporting cadence agreed.
- 5Go live & report
Execution goes live with TCA, exposure and collateral reporting from day one.
For your committee
Everything your approval process will ask for.
Institutional onboarding is won or lost in the committee room. Drovix prepares the document set your board, risk and compliance functions will request — before they ask. Policy documents are published openly; counterparty-specific items are issued during review.
Your relationship manager assembles the full pack against your internal checklist, in the format your governance process requires.
- Regulatory status & licence detailView
- Terms & institutional services agreementView
- Order execution policyView
- Risk disclosureView
- AML / CDD policyView
- Complaints handling procedureView
- Custody & collateral arrangements summaryOn review
- Sample TCA & best-execution reportOn review
- Settlement corridors & operational runbookOn review
What institutions receive
Coverage, control and accountability — under one relationship
Every Drovix institutional relationship is supported by execution, collateral and reporting frameworks designed for regulated institutions and corporate treasuries.
Multi-asset under one ISA
Five asset classes, one account, one collateral pool — cross-margined for capital efficiency.
Governance-grade reporting
Benchmarked fills, TCA and exposure reporting built for committees, auditors and boards.
Named institutional coverage
A dedicated relationship manager across onboarding, settlement and day-to-day operations.
Bring global markets under one relationship.
Eligible institutions and corporate treasuries can begin the counterparty review process via the portal, or speak with the desk about mandate scoping.
Risk notice. Engaging in leveraged products such as Forex and CFDs involves a high level of risk. The Drovix offering is directed at Eligible Counterparties and Professional Clients and is not intended for retail clients. Leverage can amplify both profits and losses; a counterparty may lose more than its initial margin. Ensure that the firm understands how these products work and can bear the risk of capital loss.
Scope. Drovix is not a public exchange, multilateral trading facility (MTF), organised trading facility (OTF) or ECN. Drovix acts as a principal counterparty in bilateral OTC transactions with approved institutional counterparties, and may internalise or route flow to third-party liquidity providers to maintain best execution under prevailing market conditions.
No retail. Drovix does not provide liquidity, execution or any related services to retail clients. Services are offered only to approved professional clients, eligible counterparties and institutional clients — including corporate entities trading for their own account — and not in jurisdictions where Drovix is not authorised or permitted to provide them.